Weight decreased
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
VITILIGO-ASSOCIATED MULTIPLE AUTOIMMUNE DISEASE SUSCEPTIBILITY 1 (finding)
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population.
|
20518838 |
2010 |
Vitiligo
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Transforming growth factor beta receptor II (TGFBR2) polymorphisms and the association with nonsegmental vitiligo in the Korean population.
|
20518838 |
2010 |
Visual field defects
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Vertebral artery aneurysm
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Vertebral Artery Aneurysm Mimicking as Left Subclavian Artery Aneurysm in a Patient with Transforming Growth Factor Beta Receptor II Mutation.
|
26169464 |
2015 |
Ventricular Septal Defects
|
0.020 |
GeneticVariation
|
group |
BEFREE |
Stratified analysis by gender revealed that the TGFBR2 rs6785358 genotype and allele frequency were significantly different between the CVSD case and controls, in both the male subgroup and the female subgroup (all P < 0.001).
|
26022443 |
2015 |
Ventricular Septal Defects
|
0.020 |
GeneticVariation
|
group |
BEFREE |
We report on a neonate with the disorder caused by a known TGFBR2 mutation, who developed neonatal-onset progressive dilation of the aortic valve and aneurysms of the aortic root and main pulmonary artery (PA) associated with a large left-to-right shunt via a ventricular septal defect (VSD) and an atrial septal defect.
|
20101701 |
2010 |
Ventricular Dysfunction, Left
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Ventricular arrhythmia
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
We show an association between a common TGFBR2 polymorphism and risk of SCA caused by VA in the setting of CAD.
|
19959123 |
2009 |
Vascular lesions
|
0.010 |
Biomarker
|
disease |
BEFREE |
We propose that microsatellite instability in TbetaR-II disables growth inhibitory pathways, allowing monoclonal selection of a disease-prone cell type within some vascular lesions.
|
9410894 |
1997 |
Vascular Diseases
|
0.010 |
GeneticVariation
|
group |
LHGDN |
Mutations in either TGFBR1 or TGFBR2 predispose patients to aggressive and widespread vascular disease.
|
16928994 |
2006 |
Vascular Diseases
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Mutations in either TGFBR1 or TGFBR2 predispose patients to aggressive and widespread vascular disease.
|
16928994 |
2006 |
Varicose Ulcer
|
0.010 |
Biomarker
|
disease |
BEFREE |
Using quantitative polymerase chain reaction (qPCR) and immunohistochemical analysis, we found suppression of TGFbeta RI, TGFbeta RII and TGFbeta RIII, and complete absence of phosphorylated Smad2 (pSmad2) in VU epidermis.
|
20069132 |
2010 |
Uterine Rupture
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Urologic Neoplasms
|
0.100 |
Biomarker
|
group |
HPO |
|
|
|
Uranostaphyloschisis
|
0.110 |
Biomarker
|
disease |
BEFREE |
Cleft palate in Tgfbr2 mutant mice results from a cell proliferation defect within the CNC-derived palatal mesenchyme.
|
12975342 |
2003 |
Uranostaphyloschisis
|
0.110 |
CausalMutation
|
disease |
CLINVAR |
Arthrogryposis as neonatal presentation of Loeys-Dietz syndrome due to a novel TGFBR2 mutation.
|
28344185 |
2017 |
Undifferentiated carcinoma
|
0.300 |
Biomarker
|
disease |
CTD_human |
A dominant negative mutation of transforming growth factor-beta receptor type II gene in microsatellite stable oesophageal carcinoma.
|
10789724 |
2000 |
Ulcerative Colitis
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
The carcinogenesis process in ulcerative colitis-associated colorectal cancer was closely associated with the microsatellite instability pathway through TGFbetaRII mutation by a dysfunction of the mismatch repair system.
|
18546042 |
2008 |
Ulcerative Colitis
|
0.020 |
Biomarker
|
disease |
BEFREE |
We thus treated simple Tgfbr2(ΔIEC) mice with dextran sodium sulfate (DSS) that causes ulcerative colitis.
|
25687406 |
2015 |
Turcot syndrome (disorder)
|
0.020 |
GeneticVariation
|
disease |
BEFREE |
TGF-β receptor type 2 (<i>TGFBR2</i>) mutations affected by a mismatch repair deficiency causes colorectal cancers (CRCs) with microsatellite instability, which is, however, associated with relatively better survival rates.
|
31756952 |
2019 |
Turcot syndrome (disorder)
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
For mismatch repair deficiency and transforming growth factor β receptor type II (TGFBRII) overexpression there was a borderline association with a poorer prognosis (HR = 0.69, 95%CI: 0.46 - 1.04 and HR = 2.11, 95%CI: 1.02 - 4.40, respectively).
|
21362268 |
2011 |
Tumor Progression
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Mutations in TGFbeta-RII and BAX mediate tumor progression in the later stages of colorectal cancer with microsatellite instability.
|
20565851 |
2010 |
Tumor Progression
|
0.100 |
GeneticVariation
|
phenotype |
BEFREE |
Our results contribute to the understanding of how the TGFBR2 and BAX gene mutations contribute to tumor progression in the mutator phenotype pathway for MSI colorectal cancers.
|
15676142 |
2005 |
Tumor Progression
|
0.100 |
Biomarker
|
phenotype |
BEFREE |
In conclusion, in lung cancer cells, SCUBE3 could serve as an endogenous autocrine and paracrine ligand of TGF-β type II receptor, which could regulate TGF-β receptor signaling and modulate EMT and cancer progression.
|
21441952 |
2011 |